From fatty liver to fibrosis: A tale of "second hit"

被引:123
作者
Basaranoglu, Metin [1 ]
Basaranoglu, Gokcen [2 ]
Senturk, Hakan [1 ]
机构
[1] Bezmialem Vakif Univ, TR-34400 Istanbul, Turkey
[2] Bezmialem Vakif Univ, Dept Anaesthesiol, TR-34400 Istanbul, Turkey
关键词
Fatty liver; Oxidative stress; Fibrosis; Nonalcoholic fatty liver diseases; Nonalcoholic steatohepatitis; HEPATIC STELLATE CELLS; OXIDATIVE STRESS; NONALCOHOLIC STEATOHEPATITIS; CRYPTOGENIC CIRRHOSIS; INSULIN-RESISTANCE; GENE-EXPRESSION; DISEASE; OBESITY; AMINOTRANSFERASE; PROTEOMICS;
D O I
10.3748/wjg.v19.i8.1158
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Although much is known about how fat accumulates in the liver, much remains unknown about how this causes sustained hepatocellular injury. The consequences of injury are recognized as nonalcoholic steatohepatitis (NASH) and progressive fibrosis. The accumulation of fat within the hepatocytes sensitizes the liver to injury from a variety of causes and the regenerative capacity of a fatty liver is impaired. An additional stressor is sometimes referred to as a "second hit" in a paradigm that identifies the accumulation of fat as the "first hit". Possible candidates for the second hit include increased oxidative stress, lipid peroxidation and release of toxic products such as malondialdehyde and 4-hydroxynonenal, decreased antioxidants, adipocytokines, transforming growth factor (TGF)-beta, Fas ligand, mitochondrial dysfunction, fatty acid oxidation by CYPs (CYP 2E1, 4A10 and 4A14), and peroxisomes, excess iron, small intestinal bacterial overgrowth, and the generation of gut-derived toxins such as lipopolysaccharide and ethanol. Oxidative stress is one of the most popular proposed mechanisms of hepatocellular injury. Previous studies have specifically observed in-creased plasma and tissue levels of oxidative stress markers and lipid peroxidation products, with reduced hepatic and plasma levels of antioxidants. There is also some indirect evidence of the benefit of antioxidants such as vitamin E, S-adenosylmethionine, betaine, phlebotomy to remove iron, and N-acetylcysteine in NASH. However, a causal relationship or a pathogenic link between NASH and oxidative stress has not been established so far. A number of sources of increased reactive oxygen species production have been established in NASH that include proinflammatory cytokines such as tumor necrosis factor (TNF)-alpha, iron overload, overburdened and dysfunctional mitochondria, CYPs, and peroxisomes. Briefly, the pathogenesis of NASH is multifactorial and excess intracellular fatty acids, oxidant stress, ATP depletion, and mitochondrial dysfunction are important causes of hepatocellular injury in the steatotic liver. (C) 2013 Baishideng. All rights reserved.
引用
收藏
页码:1158 / 1165
页数:8
相关论文
共 71 条
  • [1] A controlled trial of gemfibrozil in the treatment of patients with nonalcoholic steatohepatitis
    Basaranoglu, M
    Acbay, O
    Sonsuz, A
    [J]. JOURNAL OF HEPATOLOGY, 1999, 31 (02) : 384 - 384
  • [2] Pathophysiology of insulin resistance and steatosis in patients with chronic viral hepatitis
    Basaranoglu, Metin
    Basaranoglu, Gokcen
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2011, 17 (36) : 4055 - 4062
  • [3] Mallory-Denk Bodies in chronic hepatitis
    Basaranoglu, Metin
    Turhan, Nesrin
    Sonsuz, Abdullah
    Basaranoglu, Gokcen
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2011, 17 (17) : 2172 - 2177
  • [4] Liver fibrosis
    Bataller, R
    Brenner, DA
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2005, 115 (02) : 209 - 218
  • [5] Gene expression in two hepatic cell lines, cultured primary hepatocytes, and liver slices compared to the in vivo liver gene expression in rats:: Possible implications for toxicogenomics use of in vitro systems
    Boess, F
    Kamber, M
    Romer, S
    Gasser, R
    Muller, D
    Albertini, S
    Suter, L
    [J]. TOXICOLOGICAL SCIENCES, 2003, 73 (02) : 386 - 402
  • [6] Is liver fibrosis reversible?
    Bonis, PAL
    Friedman, SL
    Kaplan, MM
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (06) : 452 - 454
  • [7] Bradbury Michael W, 2004, Clin Liver Dis, V8, P639, DOI 10.1016/j.cld.2004.04.005
  • [8] Relative contribution of iron burden, HFE mutation and insulin resistance to fibrosis in nonalcoholic fatty liver
    Bugianesi, E
    Manzini, P
    D'Antico, S
    Vanni, E
    Longo, F
    Leone, N
    Massarenti, P
    Piga, A
    Marchesini, G
    Rizzetto, M
    [J]. HEPATOLOGY, 2004, 39 (01) : 179 - 187
  • [9] Cryptogenic cirrhosis: Clinical characterization and risk factors for underlying disease
    Caldwell, SH
    Oelsner, DH
    Iezzoni, JC
    Hespenheide, EE
    Battle, EH
    Driscoll, CJ
    [J]. HEPATOLOGY, 1999, 29 (03) : 664 - 669
  • [10] Caldwell SH, 2004, CLIN LIVER DIS, V8, px